These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 32288512)
1. Biodegradable polymers for modern vaccine development. Bose RJ; Kim M; Chang JH; Paulmurugan R; Moon JJ; Koh WG; Lee SH; Park H J Ind Eng Chem; 2019 Sep; 77():12-24. PubMed ID: 32288512 [TBL] [Abstract][Full Text] [Related]
2. Long-Term Vaccine Delivery and Immunological Responses Using Biodegradable Polymer-Based Carriers. Malek-Khatabi A; Tabandeh Z; Nouri A; Mozayan E; Sartorius R; Rahimi S; Jamaledin R ACS Appl Bio Mater; 2022 Nov; 5(11):5015-5040. PubMed ID: 36214209 [TBL] [Abstract][Full Text] [Related]
3. An overview of biodegradable nanomaterials and applications in vaccines. Yan X; Zhou M; Yu S; Jin Z; Zhao K Vaccine; 2020 Jan; 38(5):1096-1104. PubMed ID: 31813649 [TBL] [Abstract][Full Text] [Related]
4. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems. Gupta RK; Chang AC; Siber GR Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260 [TBL] [Abstract][Full Text] [Related]
5. Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms. Wilson-Welder JH; Boggiatto P; Nally JE; Wafa EI; Alt DP; Hornsby RL; Frank A; Jones DE; Olsen SC; Bowden NB; Salem AK Vaccine; 2020 Apr; 38(18):3464-3473. PubMed ID: 32204939 [TBL] [Abstract][Full Text] [Related]
6. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines. Jin Z; Gao S; Cui X; Sun D; Zhao K Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213 [TBL] [Abstract][Full Text] [Related]
7. Safety and biocompatibility of injectable vaccine adjuvants composed of thermogelling block copolymer gels. Adams JR; Senapati S; Haughney SL; Wannemuehler MJ; Narasimhan B; Mallapragada SK J Biomed Mater Res A; 2019 Aug; 107(8):1754-1762. PubMed ID: 30972906 [TBL] [Abstract][Full Text] [Related]
8. Are chitosan natural polymers suitable as adjuvant/delivery system for anti-tuberculosis vaccines? Khademi F; Taheri RA; Yousefi Avarvand A; Vaez H; Momtazi-Borojeni AA; Soleimanpour S Microb Pathog; 2018 Aug; 121():218-223. PubMed ID: 29800697 [TBL] [Abstract][Full Text] [Related]
9. Natural Polymeric Composites Derived from Animals, Plants, and Microbes for Vaccine Delivery and Adjuvant Applications: A Review. Nordin AH; Husna SMN; Ahmad Z; Nordin ML; Ilyas RA; Azemi AK; Ismail N; Siti NH; Ngadi N; Azami MSM; Mohamad Norpi AS; Reduan MFH; Osman AY; Pratama DAOA; Nabgan W; Shaari R Gels; 2023 Mar; 9(3):. PubMed ID: 36975676 [TBL] [Abstract][Full Text] [Related]
10. Potentiating the Immune Responses of HBsAg-VLP Vaccine Using a Polyphosphoester-Based Cationic Polymer Adjuvant. Liu X; Liu Y; Yang X; Lu X; Xu XN; Zhang J; Chen R ACS Appl Mater Interfaces; 2023 Oct; 15(42):48871-48881. PubMed ID: 37816068 [TBL] [Abstract][Full Text] [Related]
11. Adjuvants in perspective. Vogel FR Dev Biol Stand; 1998; 92():241-8. PubMed ID: 9554280 [TBL] [Abstract][Full Text] [Related]
12. In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector. Li Y; Beitelshees M; Fang L; Hill A; Ahmadi MK; Chen M; Davidson BA; Knight P; Smith RJ; Andreadis ST; Hakansson AP; Jones CH; Pfeifer BA Sci Adv; 2016 Jul; 2(7):e1600264. PubMed ID: 27419235 [TBL] [Abstract][Full Text] [Related]
13. Applications of Chitosan Derivatives as Adjuvant for Nanoparticles Based Vaccines. Narayanan RR; Maanvizhi S Infect Disord Drug Targets; 2023; 23(3):e220922209066. PubMed ID: 36154588 [TBL] [Abstract][Full Text] [Related]
14. The potential of polyphosphazenes for delivery of vaccine antigens and immunotherapeutic agents. Eng NF; Garlapati S; Gerdts V; Potter A; Babiuk LA; Mutwiri GK Curr Drug Deliv; 2010 Jan; 7(1):13-20. PubMed ID: 19863483 [TBL] [Abstract][Full Text] [Related]
15. Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review. Khademi F; Derakhshan M; Yousefi-Avarvand A; Tafaghodi M Iran J Basic Med Sci; 2018 Feb; 21(2):116-123. PubMed ID: 29456807 [TBL] [Abstract][Full Text] [Related]
16. Polymer-mediated delivery of vaccines to treat opioid use disorders and to reduce opioid-induced toxicity. Gradinati V; Baruffaldi F; Abbaraju S; Laudenbach M; Amin R; Gilger B; Velagaleti P; Pravetoni M Vaccine; 2020 Jun; 38(30):4704-4712. PubMed ID: 32439214 [TBL] [Abstract][Full Text] [Related]